RhumbLine Advisers’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-31,231
| Closed | -$30.3K | – | 4192 |
|
|
2025
Q1 | $30.3K | Buy |
31,231
+2,315
| +8% | +$2.25K | ﹤0.01% | 3669 |
|
|
2024
Q4 | $42.8K | Buy |
28,916
+520
| +2% | +$769 | ﹤0.01% | 3685 |
|
|
2024
Q3 | $60.2K | Sell |
28,396
-4,151
| -13% | -$8.8K | ﹤0.01% | 3652 |
|
|
2024
Q2 | $79.4K | Buy |
+32,547
| New | +$79.4K | ﹤0.01% | 3582 |
|
|
2022
Q2 | – | Sell |
-22,550
| Closed | -$99K | – | 3155 |
|
|
2022
Q1 | $99K | Buy |
22,550
+3,245
| +17% | +$14.2K | ﹤0.01% | 2886 |
|
|
2021
Q4 | $230K | Buy |
+19,305
| New | +$230K | ﹤0.01% | 2795 |
|